These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10519590)

  • 1. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH; Frank CM; Dunkel IJ
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New retinoblastoma tumor formation in children initially treated with systemic carboplatin.
    Lee TC; Hayashi NI; Dunkel IJ; Beaverson K; Novetsky D; Abramson DH
    Ophthalmology; 2003 Oct; 110(10):1989-94; discussion 1994-5. PubMed ID: 14522776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
    Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
    Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavitary changes in retinoblastoma: relationship to chemoresistance.
    Mashayekhi A; Shields CL; Eagle RC; Shields JA
    Ophthalmology; 2005 Jun; 112(6):1145-50. PubMed ID: 15885779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP; Shields C; Meadows AT
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
    Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.
    Munier FL; Soliman S; Moulin AP; Gaillard MC; Balmer A; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1084-7. PubMed ID: 22368262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.
    Murray TG; Cicciarelli N; O'Brien JM; Hernández E; Mueller RL; Smith BJ; Feuer W
    Arch Ophthalmol; 1997 Oct; 115(10):1286-90. PubMed ID: 9338675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
    Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
    Jehanne M; Lumbroso-Le Rouic L; Savignoni A; Aerts I; Mercier G; Bours D; Desjardins L; Doz F
    Pediatr Blood Cancer; 2009 May; 52(5):637-43. PubMed ID: 19148943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.